Related Experiment Videos
[Fluctuations]
1Clinique Neurologique, Centre d'Investigation Clinique, INSERM U437, CHU Nantes.
Revue Neurologique
|April 15, 2003
Summary
Dopamine treatment fluctuations in Parkinson's disease, affecting over half of patients after 5 years, stem from brain dopamine changes and basal ganglia issues. Understanding these mechanisms is key to managing motor symptoms effectively.
Area of Science:
- Neuroscience
- Pharmacology
- Neurology
Context:
- Parkinson's disease (PD) management often involves dopaminergic therapy.
- Motor fluctuations are a common and debilitating complication of long-term PD treatment.
- Over 50% of PD patients experience fluctuations after 5 years of therapy.
Purpose:
- To elucidate the underlying mechanisms of dopaminergic treatment efficacy fluctuations in Parkinson's disease.
- To highlight the importance of semiologic analysis in understanding these fluctuations.
Summary:
- Fluctuations in dopaminergic treatment efficacy manifest as intermittent recurrence of parkinsonian motor symptoms.
- These complications arise from both disease progression and the therapeutic interventions themselves.
- Key mechanisms include pharmacokinetic alterations in brain dopamine storage and complex postsynaptic abnormalities within the basal ganglia circuitry.
Impact:
- Improved understanding of fluctuation mechanisms can guide more effective therapeutic strategies.
- Accurate semiologic assessment is crucial for tailoring interventions to individual patient needs.
- This knowledge is essential for developing treatments to mitigate motor complications in Parkinson's disease.